Impact Of Bronchoscopy After First-Line Chemotherapy In Patients With Stage Iv Non Small Cell Lung Cancer On Overall Survival

被引：0
|
作者：
Dayen, C. [1 ]
Trouve, C. [1 ]
Poulet, C. [2 ]
Gubler, B.
Sevestre, H. [3 ]
Suguenot, R. [1 ]
Bentayeb, H. [1 ]
Rault, I. [1 ]
Lecuyer, E. [1 ]
Hoguet, E. [4 ]
Le Meunier, F. [1 ]
Jounieaux, V. [2 ]
Benzerdjeb, N. [3 ]
Andrejak, C. [1 ]
Douadi, Y. [1 ]
机构：
[1] CHG St Quentin, St Quentin en Yvelines, France
[2] Pneumol Unit, Amiens, France
[3] Pathol Unit, Amiens, France
[4] CH Abbeville, Pneumol Unit, Abbeville, France
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2016年 / 193卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3397
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A phase II study of pemetrexed and gemcitabine plus bevacizumab as first-line chemotherapy for elderly patients with stage IIIb/IV non-small cell lung cancer
    Blakely, L.
    Schwartzberg, L. S.
    Schnell, F. M.
    Sabbath, K. D.
    Miller, P. J.
    Stepanski, E. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [42] Survival among non-small cell lung cancer patients with poor performance status after first line chemotherapy
    Salloum, Ramzi G.
    Smith, Thomas J.
    Jensen, Gail A.
    Lafata, Jennifer Elston
    LUNG CANCER, 2012, 77 (03) : 545 - 549
  • [43] Temporal Trend of Overall Survival in Patients with Advanced Non-small Cell Lung Cancer Given First-Line Cytotoxic Treatments Response
    Qi, Wei-xiang
    Yao, Yang
    LUNG, 2012, 190 (06) : 592 - 592
  • [44] Mechanism underlying the effect of Liujunzi decoction (sic) on advanced-stage non-small cell lung cancer in patients after first-line chemotherapy
    Xin Xiaoli
    Wang Guodong
    Han Ru
    Jiang Yi
    Liu Chang
    Liu Lingshuang
    Xu Zhenye
    JOURNAL OF TRADITIONAL CHINESE MEDICINE, 2022, 42 (01) : 108 - 115
  • [45] Evaluation of weight gain and overall survival of patients with advanced non-small cell lung cancer (NSCLC) treated with first-line platinum-based chemotherapy.
    Roeland, Eric
    Fintelmann, Florian J.
    Hilton, Fiona
    Tarasenko, Lisa
    Calle, Roberto A.
    Bonomi, Philip D.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [46] Evaluation of weight gain and overall survival of male vs. female patients with advanced non-small cell lung cancer (NSCLC) receiving first-line chemotherapy
    Roeland, E. J.
    Fintelmann, F. J.
    Yang, R.
    Tarasenko, L. C.
    Mcrae, T. D.
    Revkin, J. H.
    Bonomi, P. D.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1125 - S1125
  • [47] Overall Survival Analyses following Adjuvant Chemotherapy or Nonadjuvant Chemotherapy in Patients with Stage IB Non-Small-Cell Lung Cancer
    Tu, Zegui
    Tian, Tian
    Chen, Qian
    Li, Caili
    JOURNAL OF ONCOLOGY, 2021, 2021
  • [48] EGFR Exon 19 Deletion is Associated With Favorable Overall Survival After First-line Gefitinib Therapy in Advanced Non-Small Cell Lung Cancer Patients
    Choi, Yong Won
    Jeon, So Yeon
    Jeong, Geum Sook
    Lee, Hyun Woo
    Jeong, Seong Hyun
    Kang, Seok Yun
    Park, Joon Seong
    Choi, Jin-Hyuk
    Koh, Young Wha
    Han, Jae Ho
    Sheen, Seung Soo
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (04): : 385 - 390
  • [49] Anlotinib Plus Standard Chemotherapy as First-line Treatment in Extensive-Stage Small Cell Lung Cancer Patients
    Zhang, W.
    Yang, H.
    Kong, T.
    Han, B.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S536 - S536
  • [50] Anlotinib plus standard chemotherapy as first-line treatment in extensive-stage small cell lung cancer patients
    Zhang, W.
    Yang, H.
    Kong, T.
    Han, B.
    ANNALS OF ONCOLOGY, 2022, 33 : S1580 - S1580
12345